Upping the Migraine Intelligence Quotient: Real-world data sheds light on prevalence rates, providers and treatment variation

In the U.S., migraine patients spend an average of $9,000 more than those without the diagnosis. Prevalence estimates in the U.S. range between 12% to 16% of the population. Claims data can provide insights needed to further hone migraine treatment. In this case study, you will learn variation of migraine prevalence within patient and treatment cohorts, variation that exists across healthcare provider specialties in relation to migraine treatment approaches, and more. Download now.